Class information for:
Level 2: BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
157 21931 36.6 77%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
213 47427 PROSTATE CANCER//PROSTATIC NEOPLASMS//RADICAL PROSTATECTOMY

Classes in level below (level 1)


ID, lev. below Publications Label for level below
714 3070 LOWER URINARY TRACT SYMPTOMS//BENIGN PROSTATIC HYPERPLASIA//LUTS
1208 2691 ABIRATERONE//ENZALUTAMIDE//CASTRATION RESISTANT PROSTATE CANCER
1718 2440 ANDROGEN RECEPTOR//ANDROGEN INSENSITIVITY SYNDROME//ANDROGEN INSENSITIVITY
1802 2409 ANDROGEN DEPRIVATION THERAPY//INTERMITTENT ANDROGEN SUPPRESSION//BICALUTAMIDE
3082 1989 PROSTATE DEVELOPMENT//BIOL SCI VET MED//PROSTATE STEM CELL
6661 1384 LZTS1//UROGENE//NUCLEAR ROUNDNESS
6989 1343 5 ALPHA REDUCTASE//FINASTERIDE//BIOL SYST ANIM PROD
7433 1288 PROSTATIC INTRAEPITHELIAL NEOPLASIA//ATYPICAL SMALL ACINAR PROLIFERATION//ALPHA METHYLACYL COA RACEMASE
7893 1239 PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3
10361 1004 NEUROENDOCRINE DIFFERENTIATION//SMALL CELL CARCINOMA//RENAL CARCINOID
18445 486 D 004//PC SPES//SERENOA REPENS
18667 475 FOSFESTROL//IDIOPATHIC URETHRITIS//5 ALPHA ANDROSTANEDIOL
19173 452 NKX31//LOBUND//3 2 DIMETHYL 4 AMINOBIPHENYL
20536 394 HUHS1015//CHRONIC PROSTATIC INFLAMMATION//NAFTOPIDIL
23694 283 SELECTIVE ANDROGEN RECEPTOR MODULATOR//SARM//SARMS
23757 281 EBP1//RADIOBIOL CANC//PA2G4
25469 232 SHIONOGI CARCINOMA 115//VITAMIN B 12B//CLIN EXPT PATHOPHYSIOL
27347 190 UNIT IMMUNOMICROBIO ENVIRONM CARCINOGENESIS//ANTI INTERLEUKIN 6 ANTIBODY//AUTOCRINE AND PARACRINE LOOPS
28888 161 PEROPERATIVE BLEEDING//PRIMARY PROSTATE CULTURE//BLOOD VESSEL MORPHOLOGY
31616 120 OSTEOBLASTIC METASTASIS//3 D COLLAGEN//AHTO 7

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 BENIGN PROSTATIC HYPERPLASIA Author keyword 674 46% 5% 1091
2 PROSTATE CANCER Author keyword 603 15% 17% 3660
3 PROSTATE Journal 544 32% 6% 1394
4 ANDROGEN RECEPTOR Author keyword 402 32% 5% 1051
5 LOWER URINARY TRACT SYMPTOMS Author keyword 389 51% 2% 542
6 CASTRATION RESISTANT PROSTATE CANCER Author keyword 341 68% 1% 296
7 ABIRATERONE Author keyword 275 85% 1% 144
8 ENZALUTAMIDE Author keyword 246 89% 1% 112
9 ABIRATERONE ACETATE Author keyword 242 94% 0% 88
10 ANDROGEN DEPRIVATION THERAPY Author keyword 222 54% 1% 289

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 BENIGN PROSTATIC HYPERPLASIA 674 46% 5% 1091 Search BENIGN+PROSTATIC+HYPERPLASIA Search BENIGN+PROSTATIC+HYPERPLASIA
2 PROSTATE CANCER 603 15% 17% 3660 Search PROSTATE+CANCER Search PROSTATE+CANCER
3 ANDROGEN RECEPTOR 402 32% 5% 1051 Search ANDROGEN+RECEPTOR Search ANDROGEN+RECEPTOR
4 LOWER URINARY TRACT SYMPTOMS 389 51% 2% 542 Search LOWER+URINARY+TRACT+SYMPTOMS Search LOWER+URINARY+TRACT+SYMPTOMS
5 PROSTATE 350 19% 7% 1634 Search PROSTATE Search PROSTATE
6 CASTRATION RESISTANT PROSTATE CANCER 341 68% 1% 296 Search CASTRATION+RESISTANT+PROSTATE+CANCER Search CASTRATION+RESISTANT+PROSTATE+CANCER
7 ABIRATERONE 275 85% 1% 144 Search ABIRATERONE Search ABIRATERONE
8 ENZALUTAMIDE 246 89% 1% 112 Search ENZALUTAMIDE Search ENZALUTAMIDE
9 ABIRATERONE ACETATE 242 94% 0% 88 Search ABIRATERONE+ACETATE Search ABIRATERONE+ACETATE
10 ANDROGEN DEPRIVATION THERAPY 222 54% 1% 289 Search ANDROGEN+DEPRIVATION+THERAPY Search ANDROGEN+DEPRIVATION+THERAPY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 FINASTERIDE 715 58% 4% 827
2 MITOXANTRONE PLUS PREDNISONE 573 71% 2% 463
3 BENIGN PROSTATIC HYPERPLASIA 534 36% 5% 1195
4 URINARY TRACT SYMPTOMS 331 37% 3% 716
5 INCREASED SURVIVAL 314 66% 1% 291
6 ABIRATERONE ACETATE 303 74% 1% 226
7 FLUTAMIDE 267 50% 2% 387
8 ANTIANDROGEN WITHDRAWAL 258 89% 1% 118
9 DEPRIVATION THERAPY 229 61% 1% 241
10 TERAZOSIN 209 67% 1% 190

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 PROSTATE 544 32% 6% 1394
2 EUROPEAN UROLOGY 76 10% 3% 706
3 PROSTATE CANCER AND PROSTATIC DISEASES 65 24% 1% 239
4 EUROPEAN UROLOGY SUPPLEMENTS 43 26% 1% 145
5 CLINICAL GENITOURINARY CANCER 16 17% 0% 87
6 LUTS-LOWER URINARY TRACT SYMPTOMS 6 16% 0% 36
7 INVESTIGATIVE UROLOGY 4 12% 0% 27
8 INTERNATIONAL NEUROUROLOGY JOURNAL 2 13% 0% 15
9 MOLECULAR UROLOGY 2 10% 0% 18
10 UROLOGIC ONCOLOGY 2 13% 0% 14

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The development of androgen-independent prostate cancer 2001 1219 88 67%
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis 2015 8 45 71%
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them 2015 8 103 61%
Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects 2015 6 151 79%
Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis 2014 29 159 78%
Androgen receptor: structure, role in prostate cancer and drug discovery 2015 4 191 70%
Androgen receptor in prostate cancer 2004 656 392 53%
A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with alpha-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia 2012 70 39 82%
Molecular genetics of prostate cancer: new prospects for old challenges 2010 224 433 53%
Androgen Receptor Rediscovered: The New Biology and Targeting the Androgen Receptor Therapeutically 2011 96 36 86%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PROSTATE CANC TARGETED THER Y GRP 51 91% 0.1% 21
2 GEORGE WHIPPLE CANC 39 38% 0.4% 81
3 BIOL SYST ANIM PROD 35 89% 0.1% 16
4 LANK GENITOURINARY ONCOL 30 37% 0.3% 64
5 PROSTATE DIS 22 27% 0.3% 71
6 MICHIGAN TRANSLAT PATHOL 22 30% 0.3% 60
7 BLADDER PROSTATE HLTH 21 78% 0.1% 14
8 S REPROD BIOL 19 40% 0.2% 37
9 NEPHROUROL SURG ANDROL 18 59% 0.1% 20
10 UROL ONCOL PROGRAM 17 46% 0.1% 27

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000017073 ENDOCRINE POLYPEPTIDE CANC//LHRH RECEPTOR//SECT EXPT MED
2 0.0000015784 PROSTATE CANCER//RADICAL PROSTATECTOMY//PROSTATECTOMY
3 0.0000015364 URETHRAL STRICTURE//URETHROPLASTY//TRANSURETHRAL RESECTION OF PROSTATE
4 0.0000010489 CLUSTERIN//ELASTOFIBROMA//ELASTOFIBROMA DORSI
5 0.0000010155 CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA
6 0.0000007728 SURAMIN//ERGOTISM//HT 29 D4 CELLS
7 0.0000006533 MAMMOGRAPHIC DENSITY//BREAST DENSITY//CANCER CAUSES & CONTROL
8 0.0000005472 CIRCULATING TUMOR CELLS//DISSEMINATED TUMOR CELLS//UTEROGLOBIN
9 0.0000005318 URINARY INCONTINENCE//PELVIC ORGAN PROLAPSE//NEUROUROLOGY AND URODYNAMICS
10 0.0000005252 CHROMATIN SUPRAORGANIZATION//ZNF703//NUCLEAR PHENOTYPES